Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intubation requirements after rocuronium and succinylcholine]

F Latorre1, A Stanek, H W Gervais

  • 1Klinik für Anästhesiologie, Johannes-Gutenberg-Universität Mainz.

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|October 1, 1996
PubMed
Summary

Rocuronium and suxamethonium provide comparable intubating conditions. Rocuronium offers a longer duration of action, while suxamethonium has a faster onset for neuromuscular blockade.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of brain biopsy in the clinical management of HIV-related focal brain lesions.

HIV medicine·2018
Same author

Gastric volvulus: a potentially fatal cause of acute abdominal pain.

BMJ case reports·2017
Same author

[The ASA Classification - solid like a rock in anesthesiology].

Der Anaesthesist·2016
Same author

ALA-induced photodynamic effect on vitality, apoptosis, and secretion of vascular endothelial growth factor (VEGF) by colon cancer cells in normoxic environment in vitro.

Photodiagnosis and photodynamic therapy·2015
Same author

Nerve localization for peripheral regional anesthesia. Recommendations of the German Society of Anaesthesiology and Intensive Care Medicine.

Der Anaesthesist·2014
Same author

Control of post-hemorrhoidectomy symptoms and wound healing by Triclosan: a randomized, double-blind, controlled trial.

Minerva chirurgica·2014

Area of Science:

  • Anesthesiology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Rocuronium is a novel non-depolarizing steroidal muscle relaxant.
  • Its short onset time makes it a potential alternative to existing neuromuscular blocking agents.

Purpose of the Study:

  • To compare the intubating conditions, onset time, and clinical duration of rocuronium (0.6 mg/kg) versus suxamethonium (1 mg/kg).

Main Methods:

  • A randomized study involving 40 adult patients (ASA I-III).
  • Anesthesia induced with fentanyl and propofol, maintained with propofol, N2O, and fentanyl.
  • Neuromuscular blockade assessed via EMG of the adductor pollicis muscle following ulnar nerve stimulation.
  • Comparison of intubating conditions, onset time, and duration of block between rocuronium and suxamethonium groups.

Related Experiment Videos

Main Results:

  • Both rocuronium and suxamethonium yielded clinically acceptable intubating conditions in 90% of patients.
  • Suxamethonium achieved a deeper neuromuscular blockade (95%) compared to rocuronium (71%) at 60 seconds post-injection (p < 0.05).
  • Suxamethonium demonstrated a significantly shorter onset time and clinical duration of relaxation than rocuronium (p < 0.05).

Conclusions:

  • Rocuronium (0.6 mg/kg) provides neuromuscular blockade with an onset of approximately 3 minutes and a clinical duration of about 30 minutes.
  • Despite pharmacodynamic differences, intubating conditions achieved with rocuronium and suxamethonium are comparable and develop at similar rates.